Skip to main content
. 2020 Jul 4;5(27):16430–16439. doi: 10.1021/acsomega.0c00577

Figure 8.

Figure 8

Morphological characterization of cells treated with Entadin lectin further stained with AO/EtBr (A) human lung cancer cell line (A-549) and (B) human cervical cancer cell line (HeLa) with varying concentrations: (a) control, (b) 0.5× IC50 μg/mL, (c) 1× IC50 μg/mL, (d) 2× IC50 μg/mL, and (e) cells treated with doxorubicin considered as a positive control.